Exabis Library
Welcome to the e-CCO Library!
P621: Secure Electronic Document Signing Uptake in Biologic Prescribing for Immune Mediate Diseases
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P622 Recovery of nutrient deficiency as a predictor of remission in inflammatory bowel diseases
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P622: Change in Dietary Inflammatory Index Score in patients with Crohn's disease and healthy volunteers following the Groningen Anti Inflammatory Diet (GrAID)
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P622: Child outcome in IBD pregnancy: early vs. late discontinuation of IFX therapy
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P622: Comparison of long-term outcomes of infliximab and adalimumab in biologic-naïve patients with ulcerative colitis
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P622: Comparison of midterm outcomes in Pediatric Crohn’s Disease patients treated with either Exclusive Enteral Nutrition or Corticosteroids around disease diagnosis– a population based study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P622: Efficacy of probiotics in inflammatory bowel disease: systematic review and meta-analysis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P622: Surgery for severely active ulcerative colitis in the era of new medical treatment: The impacts of medications on surgery avoidance, and short-term and long-term surgical outcomes
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P623 Cumulative incidence of infliximab use after a first flare of acute severe colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P623: Colorectal cancer, colectomy rates and inflammatory bowel disease activity following liver transplantation in primary sclerosing cholangitis: a systematic review and meta-analysis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P623: Mucosal eosinophils as markers of post-induction vedolizumab response in paediatric Ulcerative Colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P623: Quality of life as predictor of biological levels decay in inflammatory bowel diseases
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P623: The effectiveness and tolerability of Crohn’s disease exclusion diet in adult Crohn’s disease patients: a retrospective study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P623: The impact of SARS-CoV-2 outbreak on the treatment adherence and clinical outcome of patients with inflammatory bowel disease treated with biological agents.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P623: Therapeutic preferences and outcomes in newly diagnosed patient with inflammatory bowel diseases in the biological era in Hungary. A nationwide study based on the National Health Insurance Fund database
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P624 Maintenance of remission after treatment with Exclusive Enteral Nutrition and Azathioprine in paediatric patients with Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P624: A higher prevalence of human papillomavirus in patients with perianal fistulizing Crohn's disease compared to patients with anorectal fistula without Crohn's disease.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P624: Chromoendoscopy and narrow band imaging versus conventional white light endoscopy for detection of neoplasia in ulcerative colitis – a systematic review and meta-analysis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P624: Factors that may influence the development of anti-drug antibodies to adalimumab
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P624: Investigating the symptom burden among European patients with moderate-to-severe Crohn's disease using a real-world survey
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM